On Tuesday, Jasper Therapeutics Inc (NASDAQ: JSPR) opened lower -10.03% from the last session, before settling in for the closing price of $5.98. Price fluctuations for JSPR have ranged from $5.25 to $31.01 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 26.45% at the time writing. With a float of $11.24 million, this company’s outstanding shares have now reached $15.00 million.
Let’s look at the performance matrix of the company that is accounted for 45 employees. In terms of profitability, gross margin is 57.6%, operating margin of -3346.93%, and the pretax margin is -3095.96%.
Jasper Therapeutics Inc (JSPR) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Jasper Therapeutics Inc is 25.11%, while institutional ownership is 76.14%. The most recent insider transaction that took place on Dec 12 ’24, was worth 19,899. In this transaction Chief Operating Officer of this company sold 900 shares at a rate of $22.11, taking the stock ownership to the 25,009 shares. Before that another transaction happened on Dec 12 ’24, when Company’s Executive Officer proposed sale 900 for $22.47, making the entire transaction worth $20,223.
Jasper Therapeutics Inc (JSPR) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 26.45% per share during the next fiscal year.
Jasper Therapeutics Inc (NASDAQ: JSPR) Trading Performance Indicators
Check out the current performance indicators for Jasper Therapeutics Inc (JSPR). In the past quarter, the stock posted a quick ratio of 7.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.75, a number that is poised to hit -1.26 in the next quarter and is forecasted to reach -4.74 in one year’s time.
Technical Analysis of Jasper Therapeutics Inc (JSPR)
Jasper Therapeutics Inc (NASDAQ: JSPR) saw its 5-day average volume 0.42 million, a negative change from its year-to-date volume of 0.86 million. As of the previous 9 days, the stock’s Stochastic %D was 21.78%. Additionally, its Average True Range was 0.96.
During the past 100 days, Jasper Therapeutics Inc’s (JSPR) raw stochastic average was set at 0.63%, which indicates a significant decrease from 5.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 101.89% in the past 14 days, which was lower than the 169.54% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.54, while its 200-day Moving Average is $19.34. Nevertheless, the first resistance level for the watch stands at $5.80 in the near term. At $6.21, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.47. If the price goes on to break the first support level at $5.13, it is likely to go to the next support level at $4.87. The third support level lies at $4.46 if the price breaches the second support level.
Jasper Therapeutics Inc (NASDAQ: JSPR) Key Stats
There are currently 15,001K shares outstanding in the company with a market cap of 80.71 million. Presently, the company’s annual sales total 0 K according to its annual income of -64,470 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -18,640 K.
